Sale of OTC statins:is it a lost opportunity?

摘要

Pharmacists,who advised the pharmaceutical industry about the POM to P switch of statins in 2004,have revealed that the profession has been slow to adopt the new business opportunity which the switch offered.Noel Wicks,a member of the panel that advised simvastatin manufacturers Johnson&Johnson MSD,said:"It was a giant opportunity missed as far as the profession was concerned.It could have been a complete public health bonanza for pharmacy but we just let it slip away."The apparent failure by community pharmacists to use Zocor Heart-Pro to increase their health promotion role in the high street,was not entirely unexpected.